InsiderTrades.com logo
Tesla's Downfall is Near…. Here's The Next Big Thing
From True Market Insiders   |   Ad
This Tech Giant is About to Rock the Electric Vehicle Market and Take Over Tesla.

Click Here to see which company is secretly destroying TESLA.
Learn more.
pixel

NEPH Insider Trading (Nephros)

Insider Ownership Percentage: 8.60%
Insider Buying (Last 12 Months): $71,165.00
Insider Selling (Last 12 Months): $0.00

Nephros Insider Trading History Chart

This chart shows the insider buying and selling history at Nephros by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Nephros Share Price & Price History

Current Price: $9.10
Price Change: ▲ Price Increase of +0.37 (4.24%)
As of 09/24/2021 01:00 AM ET

This chart shows the closing price history over time for NEPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The “Tech Royalty” Retirement Plan Can Help You Live Like Royalty
From Legacy Research   |   Ad
For the first time ever, a new type of tech investment allows you to collect ongoing income. One former Wall Street insider calls them, “Tech Royalties.”

And new “Tech Royalty” savings accounts allow you to collect as much as 8%... 12%... and even 17% or more.
Find out why “Tech Royalties” may be the best asse

Nephros Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/20/2021Wesley S LoboCMOBuy1,000$7.92$7,920.00View SEC Filing Icon  
8/18/2021Tom GwydirDirectorBuy5,000$7.64$38,200.0011,031View SEC Filing Icon  
8/17/2021Andrew AstorCEOBuy2,500$7.67$19,175.0075,458View SEC Filing Icon  
11/19/2020Andrew AstorCEOBuy1,000$5.87$5,870.0072,958View SEC Filing Icon  
8/19/2020Andrew AstorCFOBuy950$7.40$7,030.0071,958View SEC Filing Icon  
5/28/2020Andrew AstorCFOBuy1,000$7.80$7,800.00
3/5/2020Daron EvansCEOBuy2,500$8.25$20,625.00
11/25/2019Oliver J SpandowDirectorBuy1,000$8.42$8,420.00
11/18/2019Daron EvansCEOBuy1,000$8.30$8,300.00
8/22/2019Andrew AstorCFOBuy1,500$6.97$10,455.00View SEC Filing Icon  
8/22/2019Daron EvansInsiderBuy2,000$6.92$13,840.00View SEC Filing Icon  
6/14/2019Andrew AstorCFOBuy35,000$0.64$22,400.00View SEC Filing Icon  
6/14/2019Daron EvansInsiderBuy43,172$0.60$25,903.20View SEC Filing Icon  
See Full Table
Insider Selling at Nephros?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Nephros and related companies.

SEC Filings (Institutional Ownership Changes) for Nephros (NASDAQ:NEPH)

57.95% of Nephros stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NEPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Nephros Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/17/2021Wexford Capital LP3,631,197$36.85M5.6%+1.9%35.541%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC15,023$0.16M0.0%-20.6%0.147%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.99,936$1.01M0.0%+3.9%0.978%Search for SEC Filing on Google Icon
8/12/2021Bard Associates Inc.231,508$2.35M0.8%+5.5%2.266%Search for SEC Filing on Google Icon
8/4/2021Cowen Prime Advisors LLC626,450$6.36M2.3%N/A6.290%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.4,574$46K0.0%+91,380.0%0.046%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC18,421$0.12M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC18,909$0.13M0.0%-10.4%0.190%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC18,421$0.12M0.0%N/A0.185%Search for SEC Filing on Google Icon
5/13/2021Wexford Capital LP3,564,530$23.70M3.5%+0.1%35.781%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.23,559$0.16M0.0%+20.9%0.237%Search for SEC Filing on Google Icon
4/27/2021Cowen Prime Services LLC622,750$4.14M1.6%+8.3%6.258%Search for SEC Filing on Google Icon
2/12/2021Elkhorn Partners Limited Partnership14,290$0.12M0.1%-9.0%0.145%Search for SEC Filing on Google Icon
2/11/2021Samjo Capital LLC550,000$4.72M4.0%N/A5.575%Search for SEC Filing on Google Icon
2/10/2021HighTower Advisors LLC55,710$0.48M0.0%+28.9%0.565%Search for SEC Filing on Google Icon
1/27/2021Cowen Prime Services LLC575,077$4.93M2.2%+86.1%5.829%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.18,333$0.13M0.0%-28.1%0.203%Search for SEC Filing on Google Icon
10/29/2020Cowen Prime Services LLC309,009$2.23M1.1%+22.6%3.418%Search for SEC Filing on Google Icon
8/12/2020Blair William & Co. IL36,249$0.30M0.0%+5.8%0.401%Search for SEC Filing on Google Icon
7/29/2020Cowen Prime Services LLC251,994$2.11M1.0%+62.8%2.798%Search for SEC Filing on Google Icon
5/18/2020Wexford Capital LP3,395,579$21.39M7.9%N/A37.699%Search for SEC Filing on Google Icon
5/4/2020Essex Investment Management Co. LLC39,863$0.25M0.1%N/A0.443%Search for SEC Filing on Google Icon
5/1/2020BlackRock Inc.8,659$54K0.0%+238.0%0.096%Search for SEC Filing on Google Icon
4/28/2020Cowen Prime Services LLC154,800$0.98M0.6%N/A1.719%Search for SEC Filing on Google Icon
4/22/2020Ingalls & Snyder LLC133,140$0.84M0.1%-1.0%1.478%Search for SEC Filing on Google Icon
2/13/2020Parkman Healthcare Partners LLC199,724$1.99M0.6%N/A2.478%Search for SEC Filing on Google Icon
2/10/2020National Asset Management Inc.14,254$0.14M0.0%-45.5%0.177%Search for SEC Filing on Google Icon
1/15/2020Ingalls & Snyder LLC134,539$1.34M0.1%+104.5%1.690%Search for SEC Filing on Google Icon
11/27/2019Millennium Management LLC38,521$0.31M0.0%N/A0.484%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Nephros logo
Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.
Read More on Nephros

Today's Range

Now: $9.10
Low: $8.31
High: $9.10

50 Day Range

MA: $8.52
Low: $7.60
High: $9.33

52 Week Range

Now: $9.10
Low: $5.08
High: $11.67

Volume

7,552 shs

Average Volume

12,365 shs

Market Capitalization

$92.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46

Who are the company insiders with the largest holdings of Nephros?

Nephros' top insider shareholders include:
  1. Andrew Astor (CEO)
  2. Andrew Astor (CFO)
  3. Tom Gwydir (Director)
  4. Daron Evans (CEO)
  5. Oliver J Spandow (Director)
  6. Wesley S Lobo (CMO)

Who are the major institutional investors of Nephros?

Nephros' top institutional investors include:
  1. Wexford Capital LP — 35.54%
  2. Cowen Prime Advisors LLC — 6.29%
  3. Bard Associates Inc. — 2.27%
  4. Vanguard Group Inc. — 0.98%
  5. Millennium Management LLC — 0.15%
  6. Advisor Group Holdings Inc. — 0.05%

Which major investors are selling Nephros stock?

In the last quarter, NEPH stock was sold by these institutional investors:
  1. Millennium Management LLC

Which major investors are buying Nephros stock?

Within the last quarter, NEPH stock was purchased by institutional investors including:
  1. Cowen Prime Advisors LLC
  2. Wexford Capital LP
  3. Bard Associates Inc.
  4. Advisor Group Holdings Inc.
  5. Vanguard Group Inc.
During the last year, these company insiders have bought Nephros stock:
  1. Andrew Astor (CEO)
  2. Andrew Astor (CFO)
  3. Tom Gwydir (Director)
  4. Daron Evans (CEO)
  5. Oliver J Spandow (Director)
  6. Wesley S Lobo (CMO)
Tesla's Downfall is Near…. Here's The Next Big Thing
From True Market Insiders   |   Ad
This Tech Giant is About to Rock the Electric Vehicle Market and Take Over Tesla.

Click Here to see which company is secretly destroying TESLA.
Learn more.
pixel